Great Point Partners LLC Insulet Corp Transaction History

Great Point Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$260.36 - $307.27 $27.2 Million - $32.1 Million	-104,600 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$225.52 - $304.06 $3.38 Million - $4.56 Million	15,000 Added 16.74%	104,600 $28.7 Million
Q1 2021 May 17, 2021	BUY	$235.95 - $293.05 $6.98 Million - $8.67 Million	29,600 Added 49.33%	89,600 $23.4 Million
Q4 2020 Feb 16, 2021	BUY	$215.97 - $265.89 $13 Million - $16 Million	60,000 New	60,000 $15.3 Million

685

62.7M

640K

881K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.1B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Great Point Partners LLC with notifications on news.